Benjamin F. Mcgraw III

All filings by Benjamin F. Mcgraw III on record concern Aerie Pharmaceuticals Inc, in the capacity of board member. The record holds 9 filings, for trades running from 8 June 2017 to 21 November 2022.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 21 November 2022: a transaction of €620k, in Aerie Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.